Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorKenneth Moise MD

About this trial

The surveillance of pregnancies at risk for fetal loss secondary to high-risk maternal or fetal conditions remains a mainstay of perinatal care. Current testing to prevent fetal loss includes the regular use of ultrasound (biophysical profile) or fetal heart rate monitoring (non-stress test) in an outpatient clinic setting once or twice weekly. A patient may also be asked to subjectively assess daily fetal movements during the time between routine antepartum testing appointments. However, there are no good systems for pregnant women to objectively measure fetal movements. Smartphones have allowed for the development of applications that utilize various embedded devices including the camera and microphone.

In our recent pilot STUDY00001552 of 205 pregnant patients, placement of the iPhone10 microphone directly on the maternal abdominal wall was utilized to detect fetal movements. AI assessment of the audio recordings proved superior to maternal perception of fetal movements that were recorded during simultaneous ultrasound (gross fetal movements: 64% audio vs 18% maternal; breathing: 93% vs 3%, hiccups: 73% vs 3%).

This trial is a prospective, observational, feasibility study of 60 patients that includes both low-risk and high-risk pregnant women to examine the usability of the Womb Watch smartphone application.

The study will involve introduction of the Womb Watch app to a population of pregnant patients. Features of the app will be modified based on participant feedback. Anxiety levels of the patient will be tracked serially using a survey tool. The various types and versions of smartphones will be assessed to see if they affect the AI model. Finally, patients will be asked to determine the strength of fetal movements to see if this parameter can be assessed by the AI model. Amniotic fluid data will assessed through clinical ultrasounds to see if this also has any effect on the AI model's ability to detect fetal movements.

Eligibility criteria

Qualifiers

Ability to understand and voluntarily provide written signed informed consent to participate in the study.

English speaking (the alpha version of the Womb Watch app is only available in English)

Singleton intrauterine pregnancy

Estimated gestational age at enrollment 28 weeks to 32 weeks

Disqualifiers

Currently pregnant with multiples (twins or more)

Baseline GAD-7 score of 10 or more

Trial design

Treatments tested in this trial

  • Smartphone Application

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

Kenneth Moise MD

Lead sponsor

University of Texas at Austin

Sponsor institution

The University of Texas Health Science Center, Houston

Collaborator

The University of Texas Medical Branch, Galveston

Collaborator